Silence Therapeutics (SLN) Balance Sheet: Assets & Liabilities

Silence Therapeutics (SLN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Silence Therapeutics reported total assets of GBP 131.44M and total liabilities of GBP 69.14M. Shareholders' equity was GBP 62.30M, down 53.5% from GBP 134.02M a year earlier. Total debt stood at GBP 160.00K against GBP 85.11M in cash and short-term investments, a net cash position of GBP 84.95M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Silence Therapeutics Balance Sheet Analysis

Values in millions GBP

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Silence Therapeutics plc (SLN) - Annual data in millions GBP
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	11.28	121.33	68.79	66.34	99.25	27.45	13.52	21.49	42.75
Short-Term Investments	73.84	26.00	0.00	19.76	0.00	10.00	20.00	5.04	0.32
Cash & Short-Term Investments	85.11	147.33	68.79	86.10	99.25	37.45	33.52	26.54	43.06
Accounts Receivable	24.61	0.97	0.29	1.11	0.45	29.31	0.00	2.45	2.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	8.93	14.68	11.63	11.79	7.46	9.64	3.95	0.52	0.48
Total Current Assets	118.66	187.37	103.15	117.01	116.52	76.40	37.47	29.50	45.55
Non-Current Assets
Property, Plant & Equipment (Net)	1.75	1.98	2.67	2.66	2.62	1.13	0.61	0.92	1.17
Long-Term Investments	0.00	0.36	0.36	0.34	0.41	0.30	0.28	-4.77	0.00
Goodwill	10.62	9.40	9.98	9.69	10.25	8.13	7.69	8.13	8.03
Intangible Assets	0.29	0.31	0.36	0.39	0.03	0.02	0.03	0.06	0.03
Other Non-Current Assets	0.13	3.24	3.65	0.00	0.00	0.00	0.00	5.04	0.23
Total Non-Current Assets	12.78	12.20	16.30	13.09	13.31	9.57	8.61	9.39	9.46
Total Assets	131.44	202.64	119.45	130.10	129.83	85.97	46.08	38.89	55.01
Current Liabilities
Accounts Payable	4.41	16.45	3.35	3.86	5.49	2.29	1.79	1.15	0.46
Short-Term Debt	0.09	0.09	0.18	0.45	0.14	0.34	0.29	0.00	0.00
Accrued Liabilities	5.75	12.05	7.85	10.15	8.39	8.06	-	-	-
Deferred Revenue	0.17	0.31	6.57	10.73	5.73	0.00	0.00	0.00	0.00
Other Current Liabilities	8.95	10.39	9.17	18.31	10.97	22.95	7.58	2.49	2.00
Total Current Liabilities	13.61	16.87	22.34	26.56	20.47	25.58	9.65	3.83	2.66
Non-Current Liabilities
Long-Term Debt	0.07	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	51.84	75.00	63.49	72.50	51.34	15.52	0.00	0.00
Total Non-Current Liabilities	55.53	51.84	75.12	76.83	97.85	51.34	15.52	1.15	0.46
Total Liabilities	69.14	68.61	97.46	103.38	118.32	76.91	25.17	3.83	2.66
Stockholders' Equity
Common Stock	10.29	8.89	8.85	6.52	6.06	4.17	3.92	3.55	3.50
Retained Earnings	-562.57	-423.36	-431.89	-318.60	-300.92	-184.22	-152.00	-133.78	-116.43
Accumulated Other Comprehensive Income	-2.21	2.08	-10.73	29.45	32.11	35.38	30.84	165.28	165.28
Additional Paid-in Capital	458.33	609.56	455.77	280.60	255.79	153.73	138.15	0.00	0.00
Shares Outstanding	141.70	141.67	118.85	107.81	89.78	-	-	-	-
Total Stockholders' Equity	62.30	134.02	21.99	26.71	11.51	9.06	20.91	35.06	52.35
Total Liabilities & Equity	97.55	202.64	119.45	130.10	129.83	85.97	46.08	38.89	55.01

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Silence Therapeutics Balance Sheet

How much debt does Silence Therapeutics have?

Silence Therapeutics had total debt of GBP 160.00K as of Dec 31, 2025, against GBP 85.11M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was GBP 93.45K a year earlier.

What are Silence Therapeutics's total assets?

Silence Therapeutics reported total assets of GBP 131.44M as of Dec 31, 2025, down 35.1% from GBP 202.63M a year earlier. Total liabilities were GBP 69.14M.

What is Silence Therapeutics's shareholders' equity?

Silence Therapeutics's shareholders' equity was GBP 62.30M as of Dec 31, 2025, or about GBP 0.44 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition